These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites. Plenge P; Gether U; Rasmussen SG Eur J Pharmacol; 2007 Jul; 567(1-2):1-9. PubMed ID: 17499240 [TBL] [Abstract][Full Text] [Related]
12. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters. Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783 [TBL] [Abstract][Full Text] [Related]
13. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine. Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792 [TBL] [Abstract][Full Text] [Related]
14. Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives. Zhou D; Zhou P; Evrard DA; Meagher K; Webb M; Harrison BL; Huryn DM; Golembieski J; Hornby GA; Schechter LE; Smith DL; Andree TH; Mewshaw RE Bioorg Med Chem; 2008 Jul; 16(14):6707-23. PubMed ID: 18571421 [TBL] [Abstract][Full Text] [Related]
15. 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors. Zhang P; Terefenko EA; Bray J; Deecher D; Fensome A; Harrison J; Kim C; Koury E; Mark L; McComas CC; Mugford CA; Trybulski EJ; Vu AT; Whiteside GT; Mahaney PE J Med Chem; 2009 Sep; 52(18):5703-11. PubMed ID: 19722525 [TBL] [Abstract][Full Text] [Related]
16. Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release. Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Swanson T; Johnson RA; Janowsky A J Pharmacol Exp Ther; 2017 Jan; 360(1):33-47. PubMed ID: 27799294 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position. Zeng F; Jarkas N; Owens MJ; Kilts CD; Nemeroff CB; Goodman MM Bioorg Med Chem Lett; 2006 Sep; 16(17):4661-3. PubMed ID: 16784855 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands. Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744 [TBL] [Abstract][Full Text] [Related]
19. Biotin tethered homotryptamine derivatives: high affinity probes of the human serotonin transporter (hSERT). Tomlinson ID; Iwamoto H; Blakely RD; Rosenthal SJ Bioorg Med Chem Lett; 2011 Mar; 21(6):1678-82. PubMed ID: 21334895 [TBL] [Abstract][Full Text] [Related]
20. Purification and fluorescent labeling of the human serotonin transporter. Rasmussen SG; Gether U Biochemistry; 2005 Mar; 44(9):3494-505. PubMed ID: 15736959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]